fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » TATA India PHARMA Healthcare Fund

TATA India PHARMA & Healthcare Fund - G

NAV  ₹9.9094 ↓ -0.15   (-1.52 %) as on 25 Feb 20

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of -0.2% since its launch.  Return for 2019 was 5.5% , 2018 was -2.6% and 2017 was 4.7% .

Below is the key information for TATA India Pharma & Healthcare Fund

NAV as on 25 Feb 20₹9.9094 ↓ -0.15   (-1.52 %)
Net Assets (AUM) as on 31 Jan 2020 ₹167 Cr.
Launch Date28 Dec 2015
CategoryEquity - Sectoral
RatingNot Rated
TypeOpen Ended Fund
RiskHigh
AMCTata Asset Management Limited
Alpha Ratio11.9
Expense Ratio2.61 %
Sharpe Ratio0.667
Information Ratio1.11
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 25 Feb 20

DurationReturns
1 Month 3.3%
3 Month 6.3%
6 Month 14.8%
1 Year 16.3%
3 Year 3.4%
5 Year
10 Year
15 Year
Since launch -0.2%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
2014
2013
2012
2011

Growth of 10k Over Years

DateValue
31 Jan 16₹10,076
31 Jan 17₹8,582
31 Jan 18₹8,947
31 Jan 19₹8,701
31 Jan 20₹9,584
TATA India PHARMA & Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash1.62%
Equity98.44%
TATA India PHARMA & Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care98.44%
TATA India PHARMA & Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 500124
14%₹24 Cr77,500
↓ -11,000
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
12%₹20 Cr466,100
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
10%₹16 Cr83,000
↓ -7,300
Abbott India Ltd (Healthcare)
Equity, Since 31 Oct 16 | 500488
9%₹16 Cr12,500
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
9%₹15 Cr210,000
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 524494
7%₹12 Cr95,000
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500126
7%₹12 Cr26,000
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
6%₹10 Cr62,000
Alembic Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 17 | 533573
5%₹8 Cr130,000
↓ -14,823
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Jan 17 | AUROPHARMA
5%₹8 Cr165,000
1 - 10 of 18
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Sailesh Jain9 Nov 181.06 Yr.
Meeta Shetty9 Nov 181.06 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

Computer Age Management Svcs
AddressNew No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam
FAX91-44-28283610
Emailenq_L@camsonline.com

Administrator Companies

CompanyAddress
Tata Mutual Fund1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051

Auditors

CompanyAddress
Deloitte Haskins & Sells12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli
M/s BSR & Co.KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
TATA India Pharma & Healthcare Fund
Normal Dividend, Reinvestment
₹9.9094
↓ -0.15
14.8 %16.3 %3.39 %-
TATA India Pharma & Healthcare Fund
Normal Dividend, Payout
₹9.9094
↓ -0.15
14.8 %16.3 %3.39 %-
TATA India Pharma & Healthcare Fund
Growth
₹9.9094
↓ -0.15
14.8 %16.3 %3.39 %-
Data as on 25 Feb 20

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.